tm logo
LYBMESCA
Live/Pending
FIFTH EXTENSION - GRANTED

granted

on 20 Feb 2024

Last Applicant/ Owned by

1-8, Doshomachi 3-chome, Chuo-ku

Osaka-shi, Osaka

JP

541-0045

Serial Number

90357057 filed on 03rd Dec 2020

Registration Number

N/A

Correspondent Address

Kumiko Ide

Wenderoth, Lind & Ponack, L.L.P.

1025 Connecticut Avenue NW, Suite 500

Washington,DC 20036

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

LYBMESCA

Pharmaceutical preparations for the treatment of cerebrovascular disease, cerebral infarction, myocardial infarction, cardiomyopathy, ischemic heart disease, epidermolysis bullosa, intractable skin ulcers, spinal cord injury, amyotrophic lateral sclerosis, traumatic brain injury, ulcerative colitis, osteoarthritis, pulmonary fibrosis and atopic dermatitis

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of cerebrovascular disease, cerebral infarction, myocardial infarction, cardiomyopathy, ischemic heart disease, epidermolysis bullosa, intractable skin ulcers, spinal cord injury, amyotrophic lateral sclerosis, traumatic brain injury, ulcerative colitis, osteoarthritis, pulmonary fibrosis and atopic dermatitis

Mark Details


Serial Number

No 90357057

Mark Type

No Service/Collective Mark

Attorney Docket Number

No TM20-0360

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
21st Feb 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
20th Feb 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
20th Feb 2024SOU EXTENSION 5 GRANTED
02th Feb 2024SOU TEAS EXTENSION RECEIVED
02th Feb 2024SOU EXTENSION 5 FILED
04th Aug 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02th Aug 2023SOU TEAS EXTENSION RECEIVED
02th Aug 2023SOU EXTENSION 4 FILED
02th Aug 2023SOU EXTENSION 4 GRANTED
23rd Feb 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED